Corporate Announcement
Security Code : 507789    Company : JAGSNPHARM    
 
Audit Committee & Investor Grievance.Download PDF Download XBRL
  Exchange Received Time  02/08/2017 14:52:48         Exchange Disseminated Time   02/08/2017 14:52:51              Time Taken   00:00:03





JPL/SEC/RESU-NOT1/ Date : August 2nd, 2017


To,

The National Stock Exchange of India Ltd.
Exchange Plaza,
Bandara-Kurla Complex
Bandra (E), Mumbai - 400 051.
Ph. 022-26598452 To,

The Bombay Stock Exchange Limited
Pherozebhoy Jeejeebhoy Tower
Dalal Street,
Mumbai - 400 001
Ph. 022-22721234

SUBJECT : NOTICE FOR BOARD MEETING TO CONSIDER
UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.06.2017



Dear Sir,


Pursuant to Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company will be held on Monday, the 14th day of August, 2017. Inter - alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended 30th June, 2017.

This Notice is also available on the website of the Company , www.jagsonpal .com and also on the website of the Bombay Stock Exchange (BSE Ltd.) www.bseindia.com .and National Stock Exchange of India (NSE) www.nseindia.com.


Thanking you.


Yours faithfully,
for JAGSONPAL PHARMACEUTICALS LIMITED




R K KAPOOR
COMPLIANCE OFFICER CUM COMPANY SECRETARY






JPL/SEC/LODR-Comp/reS-Not1 Date : August 2nd, 2017


To,

The National Stock Exchange of India Ltd.
Exchange Plaza,
Bandara-Kurla Complex
Bandra (E), Mumbai - 400 051.
Ph. 022-26598452

To,

The Bombay Stock Exchange Limited
Pherozebhoy Jeejeebhoy Tower
Dalal Street,
Mumbai - 400 001
Ph. 022-22721234


SUBJECT : Closure of Trading Window



Dear Sir,


Jagsonpal Pharmaceuticals Limited informs BSE & NSE that Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for dealing in the securities of the Company for all the persons defined under the said Regulations including Director/Officer and Employees of the Company from August 2nd, 2017 till 48hrs from the date of declaration of the Un-audited Financial Results for the year ended 30th June, 2017.


Thanking you.


Yours faithfully,
for JAGSONPAL PHARMACEUTICALS LIMITED




R K KAPOOR
COMPLIANCE OFFICER CUM COMPANY SECRETARY


 

Disclaimer

Back To Announcements